Trinity Biotech (TRIB) Return on Sales (2009 - 2024)

Trinity Biotech (TRIB) has reported Return on Sales for 16 consecutive years, with 0.0% the latest figure, recorded in Q4 2024.

• Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.01%, down 1.0% from the prior year.
• Return on Sales grew to 0.0% in Q4 2024 per TRIB's latest filing, from 0.0% in the prior quarter.
• Over the last five years, Return on Sales for TRIB reached as high as 0.01% in Q2 2023 and fell as low as 0.0% in Q4 2020.
• A 5-year average of 0.0% and a median of 0.0% in 2021 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2020 — Return on Sales advanced 1 bps — and 2024, when it dropped 1 bps.
• Year by year, Return on Sales stood at 0.0% in 2020, then jumped by 100 bps to 0.0% in 2021, then surged by 1769 bps to 0.0% in 2022, then tumbled by 101 bps to 0.0% in 2023, then tumbled by 16074 bps to 0.0% in 2024.
• According to Business Quant data, Return on Sales over the past three periods registered 0.0%, 0.0%, and 0.0% for Q4 2024, Q3 2024, and Q2 2024 respectively.